Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hudec

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 9, 2023
Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 StudyGilles Montalescot, John H Alexander, Angel Cequier-Fillat, et al.
Open Heart|August 2, 2017
Polymer-free sirolimus-eluting stents in a large-scale all-comers populationFlorian Krackhardt, Viktor Kočka, Matthias W Waliszewski, et al.
American Heart Journal|May 2, 2025
Win ratio analysis of the LANDMARK trialAkihiro Tobe, Niels van Royen, Ignacio J Amat-Santos, et al.
Cardiovascular Drugs and Therapy|March 27, 2020
Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery DiseaseFlorian Krackhardt, Matthias Waliszewski, Viktor Kočka, et al.
International Journal of Cardiology|March 4, 2019
Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registryAntonio Colombo, Jaya Chandrasekhar, Melissa Aquino, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 1, 2025
Clinical outcomes of the BioMime™ morph coronary stent system for long (30 to ≤56 mm length) coronary lesions: Three-year follow-up of the Morpheus Global RegistryPierfrancesco Agostoni, Jan-Peter Van Kuijk, Paul Knaapen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2021
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear studyDavid E Kandzari, Ajay J Kirtane, Roxana Mehran, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2021
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal TrialMarko Noc, Peep Laanmets, Aleksandar N Neskovic, et al.
Cardiology Research|December 19, 2024
Safety and Efficacy of BioMime Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: MILES Global RegistryMartin Hudec, Myung Ho Jeong, Ramiro Trillo, et al.
International Journal of Cardiology. Heart & Vasculature|September 21, 2020
1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registryJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 9, 2023
Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 StudyGilles Montalescot, John H Alexander, Angel Cequier-Fillat, et al.
Open Heart|August 2, 2017
Polymer-free sirolimus-eluting stents in a large-scale all-comers populationFlorian Krackhardt, Viktor Kočka, Matthias W Waliszewski, et al.
American Heart Journal|May 2, 2025
Win ratio analysis of the LANDMARK trialAkihiro Tobe, Niels van Royen, Ignacio J Amat-Santos, et al.
Cardiovascular Drugs and Therapy|March 27, 2020
Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery DiseaseFlorian Krackhardt, Matthias Waliszewski, Viktor Kočka, et al.
International Journal of Cardiology|March 4, 2019
Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registryAntonio Colombo, Jaya Chandrasekhar, Melissa Aquino, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 1, 2025
Clinical outcomes of the BioMime™ morph coronary stent system for long (30 to ≤56 mm length) coronary lesions: Three-year follow-up of the Morpheus Global RegistryPierfrancesco Agostoni, Jan-Peter Van Kuijk, Paul Knaapen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2021
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear studyDavid E Kandzari, Ajay J Kirtane, Roxana Mehran, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2021
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal TrialMarko Noc, Peep Laanmets, Aleksandar N Neskovic, et al.
Cardiology Research|December 19, 2024
Safety and Efficacy of BioMime Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: MILES Global RegistryMartin Hudec, Myung Ho Jeong, Ramiro Trillo, et al.
International Journal of Cardiology. Heart & Vasculature|September 21, 2020
1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registryJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Pageof 4